Cardiac Myosin Inhibition for Treatment of LVOT Obstruction in a Patient With Severe AS.

Aortic stenosis and obstructive hypertrophic cardiomyopathy are common conditions. When both are present in the same patient, the management can be challenging. We report what we believe to be the first time a cardiac myosin inhibitor has been used before transcutaneous aortic valve replacement.

Cardiac Tamponade: A Case for Point-of-Care Ultrasound.

• POCUS is increasingly being used in the evaluation of critically ill patients. • POCUS can shorten pulse check duration and prognosticate outcomes in cardiac arrest. • POCUS can identify the etiology of cardiac arrest after the first image.